← Leaderboards
Robert Figlin
University Of California Los Angeles
$4,039,155
Attributed
$4,039,155
Total exposure
8
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.9M · FY2006–13$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$11,718,836 · 9
By mechanism
P30$8,251,937 · 2
P01$1,565,719 · 1
K12$949,720 · 1
M01$839,978 · 4
U10$111,482 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Judith Cheryl Gasson$28,230,504
- Jeremy Mg Taylor$15,840,467
- Teresa E Seeman$21,772,630
- Andrew Leuchter$1,558,229
- Mark S. Litwin$9,715,210
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchProgramsResearch PersonnelMalignant NeoplasmsBasic ScienceHematologic NeoplasmsLinkResearch ActivityVisitHospitalsRecruitment ActivityInstitutionAreaCancer CenterMalignant Neoplasm Of LungBaseBone Marrow TransplantationCitiesImmunotherapeutic AgentCostFundingSymptom ManagementCancer Center Support GrantMember
Grant awards (26)
Late Stage Lung Cancer$500,447
P01 · FY2013 · CA · contact PI
Late Stage Lung Cancer$531,763
P01 · FY2012 · CA · contact PI
Late Stage Lung Cancer$533,509
P01 · FY2011 · CA · contact PI
Cancer Center Support Grant$2,342,475
P30 · FY2009 · CA · contact PI
Cancer Center Support Grant$107,415
P30 · FY2009 · CA · contact PI
Cancer Center Support Grant$100,000
P30 · FY2009 · CA · contact PI
Cancer Center Support Grant$94,753
P30 · FY2009 · CA · contact PI
Cancer Center Support Grant$49,994
P30 · FY2009 · CA · contact PI
Cancer Center Support Grant$2,342,475
P30 · FY2008 · CA · contact PI
Cancer Center Support Grant$107,415
P30 · FY2008 · CA · contact PI
Cancer Center Support Grant$95,134
P30 · FY2008 · CA · contact PI
CANCER CENTER SUPPORT GRANT$2,274,248
P30 · FY2007 · CA · contact PI
Oncology Research Career Development Program$465,178
K12 · FY2007 · CA · contact PI
CANCER CENTER SUPPORT GRANT$103,852
P30 · FY2007 · CA · contact PI
CANCER CENTER SUPPORT GRANT$61,920
P30 · FY2007 · CA · contact PI
Oncology Research Career Development Program$484,542
K12 · FY2006 · CA · contact PI
Phase II Trial of Recombinant Human Granulocyte Macrop$10,914
M01 · FY2004 · RR
CORE--CLINICAL RESEARCH UNIT$167,178
P30 · FY2002 · CA
SAFETY AND BIOLOGIC ACTIVITY OF RHU GM-CSF AND RHU IL4 TO TREAT CANCER$207,266
M01 · FY2001 · RR
ANTIGEN SPECIFIC IMMUNOTHERAPY IN MUC 1 POSITIVE PATIENTS$207,266
M01 · FY2001 · RR
SAFETY AND BIOLOGIC ACTIVITY OF RHU GM-CSF AND RHU IL4 TO TREAT CANCER$207,266
M01 · FY2001 · RR
ANTIGEN SPECIFIC IMMUNOTHERAPY IN MUC 1 POSITIVE PATIENTS$207,266
M01 · FY2001 · RR
CORE--CLINICAL RESEARCH UNIT$167,178
P30 · FY2001 · CA
TRIAL OF PEGYLATED INTERFERON A2A IN RENAL CELL CANCER$0
M01 · FY2001 · RR
CORE--CLINICAL RESEARCH UNIT$237,900
P30 · FY2000 · CA
UCLA/JCCC--SOUTHWEST ONCOLOGY GROUP$111,482
U10 · FY2000 · CA